Prolonged survival with systemic chemotherapy in an advanced malignant mesothelioma: A case report

Peritoneal mesotheliomas are very rare tumors. Their prognosis is poor, average survival does not exceed 1 year after peritoneal cytoreduction. Systemic chemotherapy is considered to have no proven value in the management of peritoneal mesotheliomas. Objective responses with systemic chemotherapy ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Elghali, Mohamed Amine, Bourigua, Rym, Belaid, Imtinene, Nasri, Salsabil, Mestiri, Sara, Yaacoub, Sara, Makni, Amine, Letaief, Rached
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874336/
https://www.ncbi.nlm.nih.gov/pubmed/33613924
http://dx.doi.org/10.1177/2036361320984527

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874336/
https://www.ncbi.nlm.nih.gov/pubmed/33613924
http://dx.doi.org/10.1177/2036361320984527

Ejemplares similares